Bioxcel Therapeutics (BTAI) Buy Rating Reiterated by Analysts at Canaccord Genuity; With $21.0000 Target; Westport Fuel Systems Inchares (WPRT) SI Increased By 3.87%

Westport Fuel Systems Inc. (NASDAQ:WPRT) Logo

Westport Fuel Systems Inchares (NASDAQ:WPRT) had an increase of 3.87% in short interest. WPRT’s SI was 2.57 million shares in May as released by FINRA. Its up 3.87% from 2.47M shares previously. With 1.09 million avg volume, 2 days are for Westport Fuel Systems Inchares (NASDAQ:WPRT)’s short sellers to cover WPRT’s short positions. The SI to Westport Fuel Systems Inchares’s float is 2.69%. The stock decreased 0.75% or $0.02 during the last trading session, reaching $2.66. About 320,602 shares traded. Westport Fuel Systems Inc. (NASDAQ:WPRT) has risen 127.01% since May 17, 2017 and is uptrending. It has outperformed by 115.46% the S&P500.

Professional analysts at Canaccord Genuity have $21.0000 price target on Bioxcel Therapeutics Inc (BTAI). Canaccord Genuity’s price target gives a potential upside of 110.21% from the company’s last stock close. The rating was disclosed in a note on 16 May.

More notable recent BioXcel Therapeutics, Inc. (NASDAQ:BTAI) news were published by: Nasdaq.com which released: “BioXcel Therapeutics Reports First Quarter 2018 Financial Results and Provides Business Update” on May 14, 2018, also Nasdaq.com with their article: “BioXcel Therapeutics to Ring the NASDAQ Stock Market Opening Bell on April 20, 2018” published on April 19, 2018, Nasdaq.com published: “BioXcel Therapeutics Announces Acceptance of Abstract at ASCO 2018 Annual Meeting” on April 26, 2018. More interesting news about BioXcel Therapeutics, Inc. (NASDAQ:BTAI) were released by: Streetinsider.com and their article: “UPDATE: HC Wainwright Starts BioXcel Therapeutics (BTAI) at Buy” published on May 03, 2018 as well as Benzinga.com‘s news article titled: “Benzinga’s Biotech Pulse: Takeda Sweetens Shire Offer Again, Menlo’s Woes Abound, Earnings Fail to Boost Amgen” with publication date: April 25, 2018.

Among 5 analysts covering Bioxcel Therapeutics Inc (BTAI), 5 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. Bioxcel Therapeutics Inc has $2500 highest and $1500 lowest target. $20.40’s average target is 104.20% above currents $9.99 stock price. Bioxcel Therapeutics Inc had 7 analyst reports since April 2, 2018 according to SRatingsIntel. UBS initiated the shares of BTAI in report on Monday, April 2 with “Buy” rating. Barclays Capital initiated it with “Buy” rating and $1500 target in Monday, April 2 report. The firm has “Buy” rating given on Monday, April 2 by BMO Capital Markets. On Monday, April 2 the stock rating was initiated by Canaccord Genuity with “Buy”. The rating was initiated by H.C. Wainwright with “Buy” on Thursday, May 3.

The stock increased 1.94% or $0.19 during the last trading session, reaching $9.99. About 38,161 shares traded. BioXcel Therapeutics, Inc. (BTAI) has 0.00% since May 17, 2017 and is . It has underperformed by 11.55% the S&P500.

BioXcel Therapeutics, Inc., a clinical stage biopharmaceutical company, focuses on novel artificial intelligence drug development in the fields of neuroscience and immuno-oncology in the United States. The company has market cap of $156.30 million. The firm is involved in developing BXCL501, a sublingual thin film formulation of dexmedetomidine designed for acute treatment of agitation resulting from neurological and psychiatric disorders; and BXCL701, an immuno-oncology agent designed for the treatment of prostate and pancreatic cancers. It currently has negative earnings. It is also developing BXCL502, a novel approach to the treatment of symptoms resulting from neurological disorders; and BXCL702, an immuno-oncology agent for hematological malignancies.

Among 7 analysts covering Westport Innovations (NASDAQ:WPRT), 5 have Buy rating, 0 Sell and 2 Hold. Therefore 71% are positive. Westport Innovations had 17 analyst reports since July 30, 2015 according to SRatingsIntel. The firm has “Sector Perform” rating given on Wednesday, November 11 by RBC Capital Markets. The firm has “Hold” rating by Cowen & Co given on Thursday, July 13. The rating was maintained by H.C. Wainwright on Tuesday, August 15 with “Buy”. Cowen & Co maintained Westport Fuel Systems Inc. (NASDAQ:WPRT) rating on Wednesday, November 15. Cowen & Co has “Hold” rating and $3.5 target. Oppenheimer initiated the shares of WPRT in report on Wednesday, August 16 with “Buy” rating. Lake Street maintained the stock with “Buy” rating in Wednesday, November 15 report. The rating was maintained by Craig Hallum on Friday, December 22 with “Buy”. The rating was maintained by Oppenheimer on Wednesday, November 15 with “Outperform”. The rating was maintained by Cowen & Co with “Hold” on Monday, September 18. RBC Capital Markets maintained Westport Fuel Systems Inc. (NASDAQ:WPRT) on Thursday, July 30 with “Sector Perform” rating.

More notable recent Westport Fuel Systems Inc. (NASDAQ:WPRT) news were published by: Globenewswire.com which released: “Westport Fuel Systems Reports First Quarter Fiscal 2018 Financial Results” on May 10, 2018, also Seekingalpha.com with their article: “Westport Fuel +3% as Q1 loss edges lower than a year ago” published on May 11, 2018, Nasdaq.com published: “Clean Energy Fuels Corp Stock Up 10%: Here’s What’s Happening” on May 02, 2018. More interesting news about Westport Fuel Systems Inc. (NASDAQ:WPRT) were released by: Nasdaq.com and their article: “Shares of Westport Fuel Systems Drop After Uninspiring First Quarter” published on May 11, 2018 as well as Nasdaq.com‘s news article titled: “Westport Fuel Systems to Announce First Quarter Results on Friday, May 11, 2018” with publication date: May 08, 2018.

Westport Fuel Systems Inc., a transportation technology company, provides low-emission engine and fuel system technologies utilizing gaseous fuels in North America, Europe, Asia, and South America. The company has market cap of $346.63 million. The firm operates in four divisions: Automotive, Industrial, Corporate and Technology Investments, and Cummins Westport Joint Venture. It currently has negative earnings. It designs, makes, and sells compressed natural gas , liquefied petroleum gas (LPG), and liquefied natural gas (LNG) components and systems to original equipment manufacturers and aftermarket customers.

Investors sentiment increased to 1.61 in Q4 2017. Its up 0.61, from 1 in 2017Q3. It increased, as 13 investors sold Westport Fuel Systems Inc. shares while 15 reduced holdings. 27 funds opened positions while 18 raised stakes. 26.10 million shares or 28.76% more from 20.27 million shares in 2017Q3 were reported. D E Shaw Incorporated holds 237,564 shares. California Pub Employees Retirement System holds 146,549 shares or 0% of its portfolio. Moreover, Marathon Cap Mgmt has 0.12% invested in Westport Fuel Systems Inc. (NASDAQ:WPRT). Moreover, Renaissance Ltd Liability Com has 0% invested in Westport Fuel Systems Inc. (NASDAQ:WPRT) for 545,132 shares. 500 are held by Thompson Davis And. Invesco stated it has 15,280 shares. Gp One Trading Ltd Partnership has 134,984 shares. Art Advsrs Ltd Liability Company reported 0.01% stake. Natl Bank Of Montreal Can reported 7,609 shares. Stratos Wealth Prtnrs invested in 0% or 1,000 shares. Dimensional Fund Ltd Partnership reported 0% stake. Valley Natl Advisers Inc invested in 0% or 50 shares. Scotia Capital has 14,573 shares for 0% of their portfolio. Paradigm Cap Mgmt Incorporated New York accumulated 50,000 shares. Wells Fargo And Mn invested in 0% or 37,441 shares.

Westport Fuel Systems Inc. (NASDAQ:WPRT) Institutional Positions Chart